Dentsply Sirona to Present at the 44th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Dentsply Sirona (Nasdaq: XRAY) will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2026 at 3:00 p.m. PT (6:00 p.m. ET).
Dan Scavilla, President and CEO, will discuss the company's Connected Dentistry portfolio, dental market trends, and progress on its return-to-growth strategy. A live audio webcast and replay will be available via the company's Investors website at https://investor.dentsplysirona.com.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
XRAY gained 3.02% with peers like NVST (+4.01%), ICUI (+4.87%), and MMSI (+4.27%) also higher, but no peers appeared in the momentum scanner and no same-day peer news was flagged.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 15 | Dividend declaration | Positive | -1.5% | Announced quarterly cash dividend of $0.16 per share with 2026 payment date. |
| Nov 06 | Earnings results | Negative | -12.7% | Q3 2025 loss with impairment charges and revised FY25 guidance under Return-to-Growth plan. |
| Oct 08 | Earnings call setup | Neutral | -1.3% | Scheduled Q3 2025 investor call and webcast with supporting financial materials. |
| Oct 02 | Leadership change | Positive | +0.1% | Appointed new Chief Commercial Officer to drive global sales and customer focus. |
| Sep 08 | Portfolio review | Positive | -2.8% | Decided to retain Wellspect Healthcare after strategic review, citing growth and cash flow. |
Recent news often met with negative or muted price reactions, even on dividends and strategic portfolio decisions.
Over the last few months, Dentsply Sirona has combined portfolio decisions, leadership changes, and financial updates with shareholder communications. A $0.16 quarterly dividend payable on January 9, 2026 followed Q3 2025 results showing $904 million in net sales and a $427 million net loss with significant impairments. Management launched a Return-to-Growth plan, adjusted FY25 guidance, and reshaped leadership, including a new CCO and CFO transition. The new J.P. Morgan conference appearance continues this pattern of active investor engagement following operational and strategic updates.
Market Pulse Summary
This announcement highlights Dentsply Sirona’s plan to present at the J.P. Morgan Healthcare Conference on January 13, 2026, where management will update investors on its Connected Dentistry portfolio, dental market trends, and return-to-growth strategy. In recent months, the company has reported a Q3 2025 net loss with impairments, adjusted guidance, and executed leadership changes. Investors may watch how conference remarks tie back to these developments and clarify progress on growth and profitability goals.
AI-generated analysis. Not financial advice.
CHARLOTTE, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026, at 3:00 p.m. PT (6:00 p.m. ET). During the presentation, Dan Scavilla, President and CEO of Dentsply Sirona, will provide an update on the Company's differentiated Connected Dentistry portfolio, dental market trends and the Company’s progress against its return-to-growth strategy.
Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com.
About Dentsply Sirona
Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona’s innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters is located in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
Contact Information
Investors:
Wade Moody
Senior Manager, Investor Relations
InvestorRelations@dentsplysirona.com
FAQ
When will Dentsply Sirona (XRAY) present at the J.P. Morgan Healthcare Conference?
Who will deliver Dentsply Sirona's presentation at the conference?
What topics will Dentsply Sirona (XRAY) cover on January 13, 2026?
How can investors access Dentsply Sirona's J.P. Morgan presentation and replay?
Will Dentsply Sirona disclose financial guidance or new deals at the January 13, 2026 presentation?
